Swissmedic Introduces Horizon Scanning Platform to Enhance Regulatory Oversight

Swissmedic has unveiled a new horizon scanning website to improve proactive regulatory measures. This initiative aims…

Scemblix® Gains Extended Therapeutic Indication Approval from Swissmedic

Swissmedic has officially announced an extension of the therapeutic indications for Scemblix®, a drug that plays…

Regulatory Update: Swissmedic Confirms Safety of Paracetamol Use During Pregnancy

Swissmedic, Switzerland’s regulatory authority for therapeutic products, has reaffirmed its position on the use of medicines…

Swissmedic Grants Initial Authorisation for VANFLYTA®: Impact on Clinical and Regulatory Practices

Swissmedic has officially authorised VANFLYTA®, marking its initial regulatory approval. This announcement, dated September 30, 2025,…